Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTyratech Com Shares Regulatory News (TYRU)

  • There is currently no data for TYRU

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Special Meeting and Acquisition Update

25 Oct 2018 07:00

RNS Number : 1084F
TyraTech, Inc.
25 October 2018
 

Embargoed until: 07.00 on 25th October 2018

 

TYRATECH, INC.

("TyraTech" or the "Company")

Special Meeting and Acquisition Update

The Directors of Tyratech (AIM: TYRU and TYR), give the following update further to the notice issued on the 28 September 2018 relating to the Company's proposed acquisition by American Vanguard Corporation ("AMVAC") at 3.15 pence per Share (the "Transaction").

The Company reminds all shareholders that the deadline for voting is 3 pm (UK) on 30th October 2018 for shares held under nominees, brokers or banks. However, shareholders are advised to check with their nominee or broker, some of whom may have set earlier deadlines for their own administrative reasons. If shareholders hold their shares via a nominee, and not in their own name, they are reminded that their method of voting is to contact the nominee or broker and give specific instructions to vote on their behalf. Those shareholders holding shares in their own name may return their proxy cards by post, fax or email a scanned copy to the Company's Registrars, Computershare: Externalproxyqueries@computershare.co.uk, by 3pm (UK) on 31st October 2018.

Full details may be found in the Proxy Statement issued on 9th October 2018, which is available on the Company's website www.tyratech.com.

Under US Delaware Law, in order for the Transaction to proceed, an overall majority of all the voting stock (not just a majority of those voting) is required to vote in favour. It is therefore very important that all shareholders vote. A non-vote has the same effect as a vote against. A separate vote, requiring a 75% majority of the votes cast is required to approve the cancellation of the Company's trading on AIM (contingent on completion of the Transaction).

The Board continues to recommend that shareholders vote FOR the approval and adoption of the Merger Agreement; and FOR the cancellation of admission of the Company's Common Stock to trading on AIM.

As outlined in the announcement issued on 28th September 2018, should TyraTech shareholders not approve the Transaction, the Independent Directors believe little, if any, cash would be available for return to TyraTech shareholders.

More information about how to vote is available on the Company's website www.tyratech.com If shareholders are unable to access the Company's website, copies of the Proxy Statement and Proxy Form are available from the Company's Registrar, Computershare, c/o The Pavillions, Bridgewater Road, Bristol, BS99 6ZY. They can be contacted on 0370 702 0000 for copies, or 0370 707 4040 with any other questions.

 

-ends-

 

For further information:

 

TyraTech Inc.

Bruno Jactel, Chief Executive Officer

Tel: +1 919 415 4340

Erica H. Boisvert, Chief Financial Officer

Tel: +1 919 415 4287

www.tyratech.com

SPARK Advisory Partners Limited (Nominated Adviser)

Matt Davis

Tel: +44 203 368 3550

WH Ireland Limited (Broker)

Adrian Hadden / Chris Viggor

Tel: +44 20 7220 1666

Belvedere Communications (PR)

John West / Kim van Beeck

Tel: +44 20 3687 2756

 

Additional information

This Announcement is for information only and does not constitute an offer or invitation to underwrite, subscribe for or otherwise acquire or dispose of any securities or investment advice in any jurisdiction, including without limitation, the United Kingdom, the United States, Australia, Canada or Japan. Persons needing advice should consult an independent financial adviser.

The distribution of this Announcement in certain jurisdictions may be restricted by law. Persons into whose possession this announcement comes are required to inform themselves about, and to observe, such restrictions. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

SPARK Advisory Partners Limited served as exclusive financial advisor to TyraTech and provided a fairness opinion to the Independent Directors. SPARK Advisory Partners Limited, which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, is acting exclusively for the Company and no one else in connection with the Transaction and will not be responsible to anyone other than the Company for providing protections afforded to clients of the Company.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ARIFKQDDCBDDFKB
Date   Source Headline
17th Dec 20154:01 pmRNSTR-1: Notification of Major Interest in Shares
4th Dec 201511:00 amRNSTR-1: Notification of major interest in shares
26th Nov 201512:51 pmRNSTR-1: Notification of Major Interest in Shares
16th Nov 20155:01 pmRNSResult of Special Meeting & Director Shareholdings
4th Nov 20157:00 amRNSPlacing and Subscription to raise £3.16m
24th Sep 20157:00 amRNSHalf Yearly Report
2nd Sep 20157:00 amRNSMigration of shares
6th Aug 20157:00 amRNSMigration of Shares
30th Jul 20154:38 pmRNSResult of AGM
3rd Jul 20155:04 pmRNSMigration of Shares
22nd Jun 20157:00 amRNSFinal Results
10th Jun 20152:22 pmRNSMigration of Shares
21st May 20155:45 pmRNSMigration of Shares
22nd Apr 20157:00 amRNSDirector's Dealings
20th Apr 20157:00 amRNSEnvance LLC amended: Sharpened strategic focus
9th Apr 20151:14 pmRNSMigration of Shares
8th Apr 20157:00 amRNSListing with Walgreens in the USA
27th Mar 20159:41 amRNSMigration of Shares and Exercise of SARs
25th Mar 20157:00 amRNSVamousse now distributed by CVS in the USA
3rd Mar 20157:00 amRNSVamousse now listed by the top 3 distributors, USA
25th Feb 20157:00 amRNSLloyds and Day Lewis Pharmacy listings
16th Feb 20155:01 pmRNSDirector's Dealings
2nd Feb 20157:00 amRNSVamousse at Walmart and Cardinal Health USA
15th Jan 20157:00 amRNSAppointment of Chief Financial Officer & Treasurer
2nd Dec 20147:00 amRNSTrading Update
1st Oct 20147:00 amRNSExercise of Warrants
29th Sep 20147:00 amRNSInterim Results
27th Aug 20147:00 amRNSVamousse products coming to Sainsbury's and Tesco
8th Aug 201410:30 amRNSHolding(s) in Company
5th Aug 201410:29 amRNSHolding(s) in Company
1st Aug 20145:49 pmRNSHolding(s) in Company
1st Aug 20142:40 pmRNSHolding(s) in Company
28th Jul 20145:35 pmRNSResult of Special Meeting & Director Shareholdings
16th Jul 20147:00 amRNSResult of AGM
16th Jul 20147:00 amRNSPlacing to raise £3.5m and launch of UK Vamousse
26th Jun 20147:00 amRNSFinal Results
22nd May 20144:02 pmRNSMigration of Shares
19th May 20146:15 pmRNSMigration of Shares
19th May 20147:00 amRNSVamousse product line available online across USA
30th Apr 20147:00 amRNSNatunex product launched across USA
24th Apr 20147:00 amRNSUSA Pest Control Patents Secured
8th Apr 20146:10 pmRNSDirector's Dealings
7th Apr 20144:41 pmRNSDirector's Dealings
1st Apr 20147:00 amRNSVamousse at over 4,000 Walmart Stores in USA
7th Mar 20147:00 amRNSMigration of Shares
6th Mar 201411:48 amRNSHolding(s) in Company
6th Mar 20147:00 amRNSAward of Share Options
24th Feb 20147:00 amRNSProposed Migration of Shares
18th Feb 20143:38 pmRNSResult of Special Meeting
13th Feb 20149:47 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.